CTE Stock Overview
Provides outsourced clinical trials logistic services in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Cryosite Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.85 |
| 52 Week High | AU$1.25 |
| 52 Week Low | AU$0.55 |
| Beta | 0.35 |
| 11 Month Change | -7.07% |
| 3 Month Change | 6.88% |
| 1 Year Change | 32.56% |
| 33 Year Change | 140.85% |
| 5 Year Change | 1,610.00% |
| Change since IPO | 94.32% |
Recent News & Updates
Cryosite (ASX:CTE) Is Due To Pay A Dividend Of A$0.02
Aug 22
With A 31% Price Drop For Cryosite Limited (ASX:CTE) You'll Still Get What You Pay For
Aug 20Recent updates
Cryosite (ASX:CTE) Is Due To Pay A Dividend Of A$0.02
Aug 22With A 31% Price Drop For Cryosite Limited (ASX:CTE) You'll Still Get What You Pay For
Aug 20Calculating The Intrinsic Value Of Cryosite Limited (ASX:CTE)
Jul 23Cryosite Limited's (ASX:CTE) 33% Jump Shows Its Popularity With Investors
May 09Subdued Growth No Barrier To Cryosite Limited's (ASX:CTE) Price
Feb 02Do Cryosite's (ASX:CTE) Earnings Warrant Your Attention?
Feb 07Should You Be Adding Cryosite (ASX:CTE) To Your Watchlist Today?
Aug 19Do Cryosite's (ASX:CTE) Earnings Warrant Your Attention?
May 02Shareholder Returns
| CTE | AU Life Sciences | AU Market | |
|---|---|---|---|
| 7D | -2.8% | -6.0% | 1.5% |
| 1Y | 32.6% | 11.8% | 17.2% |
Return vs Industry: CTE exceeded the Australian Life Sciences industry which returned 11.8% over the past year.
Return vs Market: CTE exceeded the Australian Market which returned 17.2% over the past year.
Price Volatility
| CTE volatility | |
|---|---|
| CTE Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 11.2% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: CTE's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: Insufficient data to determine CTE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 25 | n/a | www.cryosite.com |
Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through two segments: Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment offers specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, biological, and cell gene therapies depot services.
Cryosite Limited Fundamentals Summary
| CTE fundamental statistics | |
|---|---|
| Market cap | AU$42.95m |
| Earnings (TTM) | AU$1.84m |
| Revenue (TTM) | AU$12.61m |
22.7x
P/E Ratio3.3x
P/S RatioIs CTE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CTE income statement (TTM) | |
|---|---|
| Revenue | AU$12.61m |
| Cost of Revenue | AU$4.62m |
| Gross Profit | AU$7.99m |
| Other Expenses | AU$6.15m |
| Earnings | AU$1.84m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.038 |
| Gross Margin | 63.38% |
| Net Profit Margin | 14.59% |
| Debt/Equity Ratio | 0% |
How did CTE perform over the long term?
See historical performance and comparison